LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The risk of leprosy in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases: a cohort study

Photo by sammiechaffin from unsplash

Leprosy remains prevalent in developing areas, and migration renders it an increasing concern in developed countries where the incidence of immune-mediated diseases, such as psoriasis, is high. We aimed to… Click to show full abstract

Leprosy remains prevalent in developing areas, and migration renders it an increasing concern in developed countries where the incidence of immune-mediated diseases, such as psoriasis, is high. We aimed to evaluate the leprosy risk in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases. We performed a cohort study; patients were consecutively included from 2014 until 2019. The main risk factor was medication-induced immunosuppression, and the main outcome was a leprosy diagnosis. The degree of immunosuppression was quantified according to previous consensus.

Keywords: immunobiologics conventional; risk; conventional immunosuppressants; patients using; using immunobiologics; immunosuppressants treatment

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.